The Costs of Introducing the Hepatitis B Birth Dose Vaccine into the National Immunization Programme in Senegal (NéoVac Study)

Some African countries are still reluctant to introduce the hepatitis B vaccine birth dose (HepB-BD) into their expanded program of immunization (EPI), partly because of logistical, economic, and cost information constraints. To assist decision-makers in these countries, we assessed the economic and...

Descripción completa

Detalles Bibliográficos
Autores principales: Gosset, Andréa, Nishimwe, Marie Libérée, Diallo, Mamadou Yaya, Deroo, Lucas, Diallo, Aldiouma, Ba, El Hadji, Carrieri, Patrizia Maria, Sokhna, Cheikh, Vray, Muriel, Shimakawa, Yusuke, Boyer, Sylvie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8158493/
https://www.ncbi.nlm.nih.gov/pubmed/34070184
http://dx.doi.org/10.3390/vaccines9050521

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8158493/
https://www.ncbi.nlm.nih.gov/pubmed/34070184
http://dx.doi.org/10.3390/vaccines9050521

Ejemplares similares